GlassScriptPhysician profile
Advaith Bongu
NPI 1356577035
$2,378.99
in general payments reported to CMS, 2019-2025
20 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $52.59 · 2021: $565 · 2022: $429 · 2023: $430 · 2024: $237 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,174.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $789.77 | 2021-2025 | Phasix Mesh |
| Medistim USA, INC. | $270.13 | 2021 | |
| Baxter Healthcare | $249.54 | 2020-2025 | Preveleak, Floseal |
| Ethicon US, LLC | $206.56 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $139.39 | 2024 | |
| Bolton Medical INC | $135.37 | 2021 | |
| Tela Bio, INC. | $103.82 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| W. L. Gore & Associates, INC. | $76.16 | 2022-2025 | Gore Propaten Vascular Graft |
| Merck Sharp & Dohme LLC | $73.40 | 2024 | Prevymis, Verquvo |
| Organ Recovery Systems, INC. | $71.52 | 2023 | |
| Stryker Corporation | $57.84 | 2022 | |
| Melinta Therapeutics, LLC | $40.71 | 2025 | Rezzayo |
| Acera Surgical, INC. | $38.37 | 2025 | Restrata Wound Matrix |
| Medtronic, INC. | $27.06 | 2023 | Signia |
| Takeda Pharmaceuticals U.S.A., INC. | $22.06 | 2025 | Livtencity |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $19.32 | 2025 | Barostim Neo System |
| Invivyd INC | $17.29 | 2025 | Pemgarda |
| Veloxis Pharmaceuticals, INC. | $16.91 | 2024 | Envarsus |
| Daiichi Sankyo INC. | $16.78 | 2023 | Injectafer |
| Kerecis Limited | $6.99 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Advaith Bongu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.